74
Participants
Start Date
December 29, 2024
Primary Completion Date
June 30, 2025
Study Completion Date
July 20, 2025
Metformin
Metformin's chemical name is 1,1-Dimethylbiguanide, a molecular formula of C4H11N5. Beyond its well established antihyperglycemic impact, metformin demonstrated anti-oxidant and anti-inflammatory activities contributing its potential benefits in conditions associated with inflammation and oxidative stress. Furthermore, metformin rapidly crosses the blood brain barrier and disperses into several brain regions presenting an ideal therapeutic option for the treatment of PD.
placebo
placebo of tab. Metformin of same shape
BSMMU, Dhaka
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
OTHER